Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 4Gastrointestinal 3Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Pancreatic Neoplasms 1Neoplasms 1Colonic Neoplasms 1Barrett Esophagus 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Complementary Therapies × Gastrointestinal × Clear all
NCT03167970 2018-01-19

Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy

Midwest Veterans' Biomedical Research Foundation

Completed
21 enrolled
Gastrointestinal

Barrett Esophagus

NCT00003486 2013-07-10

Antineoplaston Therapy in Treating Patients With Colon Cancer

National Cancer Institute (NCI)

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms

NCT00323583 2007-05-08

Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer

Seattle Cancer Treatment and Wellness Center

Phase 2 Unknown
80 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡